GENEWIZ, Inc. Announces U.S. Expansion with San Francisco Laboratory Opening

South Plainfield, NJ -- May 29, 2013 -- GENEWIZ, Inc., leading global genomics service provider, announced expansion of its U.S. laboratory facilities with the opening of the GENEWIZ San Francisco Laboratory located in Berkeley, CA. 

"Historically, the San Francisco Bay Area has been a hot spot for biotechnology innovation and research," commented Dr. Lindsay Kendall, GENEWIZ San Francisco Manager. "Expanding our U.S. operations in the Bay Area will enable us to offer not only faster turnaround time for researchers, but also enhanced local support and expertise for the scientific community, thus enriching their overall GENEWIZ experience." 

GENEWIZ has been providing reliable, high quality DNA sequencing and genomics services to the global research community since establishment in 1999. The GENEWIZ San Francisco Laboratory will maintain the company’s commitment to delivering solid science and superior service by adding value through consistent time- and cost-saving research services.

About GENEWIZ, Inc.
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in genomics services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions. 

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; and London, United Kingdom.